Company

iRhythm Technologies, Inc.

Headquarters: San Francisco, CA, United States

Employees: 1,700

CEO: Mr. Quentin S. Blackford

NASDAQ: IRTC -3.42%

Market Cap

$3.46 Billion

USD as of Jan. 1, 2025

Market Cap History

iRhythm Technologies, Inc. market capitalization over time

Evolution of iRhythm Technologies, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of iRhythm Technologies, Inc.

Detailed Description

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Financials

Last Financial Reports Date Sept. 30, 2024
Revenue TTM $560.0 M
EBITDA $-90,648,000
Gross Profit TTM $379.9 M
Profit Margin -26.90%
Operating Margin -6.94%
Quarterly Revenue Growth 18.40%
Financial Reports & Statistics

Stocks & Indices

iRhythm Technologies, Inc. has the following listings and related stock indices.


Stock: NASDAQ: IRTC wb_incandescent

Stock: FSX: I25 wb_incandescent

Details

Headquarters:

699 8th Street

Suite 600

San Francisco, CA 94103

United States

Phone: 415 632 5700